Quay Steven C

Avg. Two Year Performance

(90%) Avg. Purchase Return
(38%) Compound
36% Avg. Sale Return
16% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return39%(11%)(20%)(66%)(90%)
Purchase Success Rate1 of 20 of 20 of 20 of 20 of 2
Average Sale Return10%< 1%1%< 1%36%
Sale Success Rate10 of 146 of 149 of 1411 of 1414 of 14

Atossa Therapeutics, Inc.

Drugs » Diagnostic Substances

President & CEO, Director:

Holdings: 4.83M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Adhera Therapeutics, Inc.

Drugs » Biotechnology

Director:

Holdings: 1.17M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--